We had a great time on April 18, talking afib research the whole evening with researchers from https://t.co/d8W0ygBSsi. Thanks to everyone for coming and making great discussions!
https://t.co/1zg9z5fZ7V
Har du interessert i forskning er dette kanskje noe for deg? Vi har utlyst 3 Phd stillinger (kardio og cerebrovaskulær tematikk) tilknyttet Forskningsavdelingen ved Bærum sykehus. Bli en del av et stimulerende og progressivt miljø 👇👇@VestreViken
https://t.co/Sp65BxL3Im
Out now: Should AF patients at intermediate stroke risk (CHA2DS2-VASc score 1) be treated with OAC?
⬇️53% lower stroke risk with OAC
⬆️2,5x higher stroke risk in non-OAC users compared to individuals without AF
@MariamAnjumMD@trygve_berge@ESC_Journals
https://t.co/lwd6qN04xc
Proud of @mortenmattings2 presenting WGS data from the GENAF study at #AHA23 today! Deleterious TTN variants is associated with AF, has impact on the structure of mouse atria & regulation of genes related to myocardial stress. @AfibNo@IdaGLunde
Does vigorous endurance exercise cause #Afib in women? Despite low prevalence of risk factors, we found a relatively high prevalence in older female athletes, suggesting exercise may promote #Afib also in women https://t.co/0pUd50gMKV @AfibNo
Thanks again for the wonderful https://t.co/d8W0ygBSsi 7th annual meeting at Lysebu in Oslo, Norway. The organizers (dr. Arnljot Tveit,@KFolkenborg & @Gene_Doctor_) are grateful for the contributions of our members and invited speakers! Recap from the inspiring sessions below 👇
The 7th annual @AfibNo meeting was a great success! Big thanks to all of the magnificent speakers and members for their invaluable contributions to atrial fibrillation research 🫀. We will give more updates soon, now that @drjohnm has introduced us to Twitter/X!
On a forest ride led by Drs Ingrid Christophersen / @pselmer we saw beautiful sites, basked in sun and, oh, BTW, at a soup stop met the Prime Minister of Norway. Really. He was nice. He waited in line for food and had rode his bike there.
“John, this is normal in Norway”
This is a great study with very nice collaboration accross three countries 🇳🇴🇦🇺🇧🇪. Happy to the study running also in Belgium!
NEXAF Detraining is the first ever RCT on effects of training intensity adaption on arrythmias in athletes: https://t.co/u6FdZfqAOy
@Open_HeartBMJ
Great to meet with NEXAF collaborators from Bærum @VestreViken Trondheim @CERG_NTNU and Tromsø @UNN_HF during the Fifth Annual Workhop of the 🇳🇴 #Afib Research Network meeting https://t.co/vOPaYv3OyA
Cyclists and other endurance athletes with atrial fibrillation in 🇳🇴🇦🇺🇧🇪: Read more about NEXAF and get in touch with the researchers at https://t.co/kSegNKNzh0 #sportscardiology